leisure time -WSS

leisure time

author：Wikipedia 2025-09-30 00:49:19 - browse：63741

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

Vertex Pharmaceuticals has spent decades trying to develop molecules that reduce pain safely and potently, searching for success in a field its own executives have dubbed a graveyard for drug discovery. Detailed data published Wednesday lent support to that quest, with a pair of company-sponsored clinical trials showing an experimental non-opioid therapy reduced pain after surgery.

The drug, VX-548, blocks signals from pain-sensitive neurons before those electrical messages reach the brain. And in a pair of randomized trials, patients given a high dose of the oral medication after bunion surgery or abdominoplasty (a tummy tuck) reported less pain than those given a placebo. Those taking lower doses of the treatment showed no improvement compared to the placebo group, however.

While the pain reduction measured by these Phase 2 trials was statistically significant, it’s unclear how meaningful the drug’s benefits were to patients, with a commentary accompanying the study describing the treatment effect as “small.” But the study authors noted that participants on a high dose of VX-548 were less likely to prematurely stop their treatment because it wasn’t working than those on placebo or participants given a combination of two common painkillers, acetaminophen and hydrocodone.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Emergency medicine has repudiated 'excited delirium.' Now what?

focus

explore

WSS

Wildfire pollution widens asthma inequities on Long Island

NIH launches clinical trials and new research office for long Covid

The FDA weighs the risks of candy

What the airline industry can learn from medicine

Traditional Chinese medicine benefits explored in new JAMA study

CDC recommends rationing of RSV shot due to shortages

explore

leisure time

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

EQRx, failed developer of low

Guidelines to prevent youth baseball injuries need more muscle

Emergency medicine has repudiated 'excited delirium.' Now what?

United colonoscopy coverage change 'may cost lives,' doctors say

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Affirmative action in medical school literally saved lives

Readout Newsletter: XBI biotech index, Akero Therapeutics

23andMe had bad news about my health. I wish a person had delivered it

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

entertainment

National panel will explore requiring free Covid tests

Infectious disease expert Jeanne Marrazzo assumes Fauci role

FDA has safety concerns on CRISPR

WHO may add ‘noma' to its list of neglected tropical diseases

Scientists inch closer to single

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

focus

focus

explore

focus